Inge Landon J - Corresponding author at: 1910 E. Innovation Park Dr., Tucson, AZ 85755, USA

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Analytical and Clinical Validation of PATHWAY Anti-HER-2/neu (4B5) Antibody to Assess HER2-low Status for Trastuzumab Deruxtecan Treatment in Breast Cancer

Charo Garrido,Melissa Manoogian, Dhiraj Ghambire, Shawn Lucas,Maha Karnoub,Matthew T. Olson,David G. Hicks,Gary Tozbikian,Aleix Prat,Naoto T. Ueno,Shanu Modi,Wenqin Feng, Judith Pugh,Ching Hsu,Junji Tsurutani,David Cameron,Nadia Harbeck, Qijun Fang,Shirin Khambata-Ford, Xuemin Liu,Landon J. Inge,Patrik Vitazka

VIRCHOWS ARCHIVno. 6 (2024): 1005-1014

引用0浏览0WOS引用

Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine

Racheal L James, Taryn Sisserson, Zhuangyu Cai, Megan E Dumas,Landon J Inge,James Ranger-Moore, Albert Mason,Callum M Sloss, Katherine McArthur

Archives of pathology & laboratory medicineno. 11 (2024): 1226-1233

引用0浏览0WOS引用

EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma

Mylan R. Blomquist,Ryan Eghlimi,Angad Beniwal,Dustin Grief, David G. Nascari,Landon Inge,Christopher P. Sereduk,Serdar Tuncali,Alison Roos, Hannah Inforzato,Ritin Sharma,Patrick Pirrotte,Shwetal Mehta,Shannon P. Fortin Ensign,Joseph C. Loftus,Nhan L. Tran

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 11 (2024)

引用0浏览0WOS引用

Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021

Jessie T. Yan, Yue Jin,Ernest Lo, Yilin Chen,Amy E. Hanlon Newell,Ying Kong,Landon J. Inge

Oncology and therapy（2023）

引用0浏览0WOS引用

Supplementary Data from Na,K-ATPase Subunits As Markers for Epithelial-Mesenchymal Transition in Cancer and Fibrosis

Sigrid A. Rajasekaran,Thu P. Huynh,Daniel Wolle,Cromwell E. Espineda,Landon J. Inge,Anna Skay, Charles Lassman, Susanne B. Nicholas, Jeffrey F. Harper,Anna E. Reeves, Mansoor M. Ahmed,James M. Leatherman, James M. Mullin, Ayyappan K. Rajasekaran

openalex（2023）

引用0浏览0引用

Supplemental Figure Legend from WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Amanda L. Richer,Jacqueline M. Cala,Kelley O'Brien,Vashti M. Carson,Landon J. Inge,Timothy G. Whitsett

crossref（2023）

引用0浏览0引用

Data from WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Amanda L. Richer,Jacqueline M. Cala,Kelley O'Brien,Vashti M. Carson,Landon J. Inge,Timothy G. Whitsett

openalex（2023）

引用34浏览0WOS引用

Supplemental Figure 2 from WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Amanda L. Richer,Jacqueline M. Cala,Kelley O'Brien,Vashti M. Carson,Landon J. Inge,Timothy G. Whitsett

crossref（2023）

引用0浏览0引用

Supplemental Figure 1 from WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Amanda L. Richer,Jacqueline M. Cala,Kelley O'Brien,Vashti M. Carson,Landon J. Inge,Timothy G. Whitsett

crossref（2023）

引用0浏览0引用

Artificial intelligence-based whole slide scoring of nuclear breast cancer IHC markers Ki67, ER, and PR matches performance of manual clinical scoring

Monesh Kapadia,Mehrnoush Khojasteh, Margarita Kouzova,Carol Jones, Xiao-Meng Xu,Matthew T. Olson,Sarah Gladden,Nancy Sapanara,Shalini Singh,Chun Chen Chen,Isaac Bai,Jim Ranger-Moore,Landon J. Inge,Uday Kurkure,Ipshita Bhattacharya, Margaret Zhao,Karel Zuiderveld,Chandana Chintakindi,Bryan Lopez,Christoph Guetter

CANCER RESEARCHno. 4 (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn